483 GlaxoSmithKline Biologicals Jun 2007

483 GlaxoSmithKline Biologicals Jun 2007

Mihaly Ligmond FDA$119.00 - Available Now

FDA investigators audited the GlaxoSmithKline Biologicals - Dresden, Germany facility and issued inspectional observations (via FDA 483) on 15 Jun 2007.

Product details

  • Category: Biologics
  • Inspection end: 15 Jun 2007
  • Location: Dresden, Germany
  • FEI: 3004835618
Add To Cart